DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Department of Defense
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation. Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the stre
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Next 90 days
Posted
05/04/2026
Closes
2026-09-30
Eligibility
Eligibility
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Program
Funding area
Science and Technology and other Research and Development - ST
Opportunity #
HT942526ALSRPTIA
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov